Lanfang Li
Impact in
- Pharmacology top 0.5%
- Apelin-related biomedical research
-
- Nuclear Receptors and Signaling
Papers in
- Pharmacology 53
- Apelin-related biomedical research 42
-
- Nuclear Receptors and Signaling 32
- Co-authors
- Linxi ChenA. Paul AlivisatosJian‐Xiong ChenHeng ZengRalph G. NuzzoLu HeZhe ChenMeiqing Liu
- Journals
- Acta Biochimica et Biophysica Sinica (23 papers)Journal of Cellular Physiology (8 papers)Clinica Chimica Acta (7 papers)The American Journal of Chinese Medicine (4 papers)PLoS ONE (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lanfang Li
173 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Pharmacology 1.1k
- Cellular and Molecular Neuroscience 739
- Cancer Research 592
- Geriatrics and Gerontology 109
- Surgery 1.0k
Countries citing papers authored by Lanfang Li
This map shows the geographic impact of Lanfang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanfang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanfang Li more than expected).
Fields of papers citing papers by Lanfang Li
This network shows the impact of papers produced by Lanfang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanfang Li. The network helps show where Lanfang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lanfang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 28 | |
| 7 | 2022 | 32 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 9 | |
| 11 | The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation Hit paper breakdown → | 2020 | 530 |
| 12 | 2018 | 38 | |
| 13 | 2018 | 105 | |
| 14 | 2017 | 19 | |
| 15 | 2017 | 3 | |
| 16 | 2016 | 0 | |
| 17 | Simultaneous Determination of Uridine,Adenosine and Epigoitrin in Compound Banlangen Granule by HPLC | 2011 | 1 |
| 18 | 2010 | 1 | |
| 19 | The Study on Alkylation Reaction of Thiophenic Compounds for Desulfurization of FCC Naphtha over USY Zeolite Catalysts | 2008 | 1 |
| 20 | Power Quality Assessment Based on FFT and Wavelet Transform | 2005 | 0 |
About Lanfang Li
Lanfang Li is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Energy Engineering and Power Technology, Biochemistry and Pharmacology, having authored 183 papers that have together received 5.1k indexed citations. Recurring topics across this work include Apelin-related biomedical research (42 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (38 papers), Nuclear Receptors and Signaling (32 papers), Autophagy in Disease and Therapy (13 papers), Lipid metabolism and disorders (10 papers), Endoplasmic Reticulum Stress and Disease (7 papers), Mitochondrial Function and Pathology (7 papers) and Sulfur Compounds in Biology (6 papers). The work is most often cited by research in Pharmacology (1.1k citations), Cellular and Molecular Neuroscience (739 citations), Cancer Research (592 citations), Geriatrics and Gerontology (109 citations) and Surgery (1.0k citations). Lanfang Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Linxi Chen, A. Paul Alivisatos, Jian‐Xiong Chen, Heng Zeng, Ralph G. Nuzzo, Lu He, Zhe Chen, Linxi Chen, Meiqing Liu and Jongseung Yoon. Their work appears in journals such as Acta Biochimica et Biophysica Sinica, Journal of Cellular Physiology, Clinica Chimica Acta, The American Journal of Chinese Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.